Author:
Patel Neeral R.,Stella Steffan Frosi,Nasser Mark,Tai Elizabeth,Hsiao Ralph,Iliuta Ioan-Andrei,Jaberi Arash,Kachura John R.,Pei York,Shlomovitz Eran
Subject
Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging
Reference9 articles.
1. Foam sclerotherapy for cyst volume reduction in autosomal dominant polycystic kidney disease: a prospective cohort study;Iliuta;Kidney Med,2019
2. Center for Drug Evaluation and Research Application Number: NDA 5970/S13. 1972. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/5970-S013_SOTRADECOL%203%25_APPROV.PDF. Accessed January 15, 2022
3. Preliminary experience with a new sclerosing foam in the treatment of varicose veins;Tessari;Dermatologic Surg,2001
4. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review;Willenberg;Phlebology,2013
5. Proposal of a new adverse event classification by the Society of Interventional Radiology Standards of Practice Committee;Khalilzadeh;J Vasc Interv Radiol,2017
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献